» Articles » PMID: 7827236

Risk of Breast Cancer in Relation to Blood Lipids: a Prospective Study of 31,209 Norwegian Women

Overview
Specialties Oncology
Public Health
Date 1994 Nov 1
PMID 7827236
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

In this prospective study, the relationship between blood lipids and breast cancer risk was examined. Between 1977 and 1983, 31,209 Norwegian women, 20 to 54 years of age, attended a health screening carried out by the Norwegian National Health Screening Services. The screening consisted of a questionnaire, anthropometric measurements, and nonfasting blood drawn for analysis of total serum cholesterol (TC), triglyceride (TG), and high density lipoprotein (HDL) cholesterol. Low density lipoprotein (LDL) cholesterol was calculated by the Friedewald's formula. During the seven to 13 years of follow-up, 302 breast cancer cases were identified by linkage to the Norwegian Cancer Registry. After adjustment for some of the known risk factors of breast cancer, the relative risk of women in the highest quartile of TC compared with women in the lowest quartile was 0.87 (95 percent confidence interval [CI] = 0.61-1.23). The corresponding relative risks and CIs were 0.82 (CI = 0.58-1.16) for TG, 1.02 (CI = 0.73-1.42) for HDL, and 0.93 (CI = 0.67-1.29) for LDL. No association between breast cancer risk and blood lipids was found in the total population, nor when the data were divided into those diagnosed before or after the age of 50 as a dividing line between pre- and postmenopausal diagnosis.

Citing Articles

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.

Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z Mol Cancer. 2025; 24(1):61.

PMID: 40025508 PMC: 11874147. DOI: 10.1186/s12943-025-02258-1.


Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.

Mirzadeh P, Oye-Somefun A, Ardern C, Buick C PLoS One. 2024; 19(3):e0299479.

PMID: 38452108 PMC: 10919642. DOI: 10.1371/journal.pone.0299479.


Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case-control study of the Multiethnic Cohort Study.

DeRouen M, Yang J, Li Y, Franke A, Tome A, White K Breast Cancer Res. 2023; 25(1):95.

PMID: 37580793 PMC: 10424359. DOI: 10.1186/s13058-023-01693-6.


Effect of Serum Lipid Profile on the Risk of Breast Cancer: Systematic Review and Meta-Analysis of 1,628,871 Women.

Nouri M, Mohsenpour M, Katsiki N, Ghobadi S, Jafari A, Faghih S J Clin Med. 2022; 11(15).

PMID: 35956117 PMC: 9369572. DOI: 10.3390/jcm11154503.


Expression of SR-B1 receptor in breast cancer cell lines, MDAMB-468 and MCF-7: Effect on cell proliferation and apoptosis.

Karimi N, Tehrani F Iran J Basic Med Sci. 2021; 24(8):1069-1077.

PMID: 34804424 PMC: 8591767. DOI: 10.22038/ijbms.2021.56752.12674.


References
1.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

2.
STALLONES R . Ischemic heart disease and lipids in blood and diet. Annu Rev Nutr. 1983; 3:155-85. DOI: 10.1146/annurev.nu.03.070183.001103. View

3.
EGGSTEIN M, KREUTZ F . [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method]. Klin Wochenschr. 1966; 44(5):262-7. DOI: 10.1007/BF01747716. View

4.
Kumar K, Sachdanandam P, Arivazhagan R . Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochem Int. 1991; 23(3):581-9. View

5.
Vatten L, Foss O . Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res. 1990; 50(8):2341-6. View